RxSight, Inc.
Data quality: 100%
RXST
Nasdaq
Manufacturing
Measuring & Analyzing Instruments
$6.83
▲
$0.06
(0.89%)
Mkt Cap: 279.37 M
Price
$6.77
Mkt Cap
279.37 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—
Quick Summary
Key Takeaways
Revenue grew 56.20% annually over 5 years — strong growth
Negative free cash flow of -19.34 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 60.09%
Capital efficient — spends only 2.85% of revenue on capex
Growth
Revenue Growth (5Y)
56.20%
Above sector avg (1.82%)
Revenue (1Y)-3.89%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-14.06%
Above sector avg (-53.34%)
ROIC-13.25%
Net Margin-28.96%
Op. Margin-35.84%
Safety
Debt / Equity
N/A
Current Ratio12.74
Interest Coverage-2536.37
Valuation
PE (TTM)
-7.17
Below sector avg (-1.47)
P/B Ratio1.01
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -7.2 | -1.5 |
| P/B | 1.0 | 1.6 |
| ROE % | -14.1 | -53.3 |
| Net Margin % | -29.0 | -41.5 |
| Rev Growth 5Y % | 56.2 | 1.8 |
| D/E | — | 0.3 |
Analyst Price Target
7 analysts
Hold
Current
$6.83
Target
$10.21
$8.00
$10.00
$13.00
Forecast
Forward P/E
-14.16
Forward EPS
-$0.48
Est. Revenue
143.89 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
-$0.48
-$0.64 – -$0.24
|
143.89 M | 4 |
| FY2026 |
-$0.65
-$0.79 – -$0.55
|
131.01 M | 4 |
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| 2026 Q2 |
-$0.17
-$0.23 – -$0.13
|
32.22 M | 4 |
| 2026 Q1 |
-$0.13
-$0.15 – -$0.12
|
29.73 M | 4 |
Earnings Surprises
Last 4 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| Q42025 | -$0.20 | -$0.03 | +84.8% |
| Q32025 | -$0.26 | -$0.04 | +84.6% |
| Q22025 | -$0.11 | -$0.08 | +29.2% |
| Q12025 | -$0.08 | -$0.03 | +62.5% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -3.89% | Revenue Growth (3Y) | 22.87% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 56.20% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 134.48 M | Net Income (TTM) | -38.94 M |
| ROE | -14.06% | ROA | -12.61% |
| Gross Margin | 76.60% | Operating Margin | -35.84% |
| Net Margin | -28.96% | Free Cash Flow (TTM) | -19.34 M |
| ROIC | -13.25% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 12.74 |
| Interest Coverage | -2536.37 | Asset Turnover | 0.44 |
| Working Capital | 261.59 M | Tangible Book Value | 275.97 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -7.17 | Forward P/E | N/A |
| P/B Ratio | 1.01 | P/S Ratio | 2.08 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -6.92% | ||
| Market Cap | 279.37 M | Enterprise Value | 249.74 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.95 | Revenue / Share | 3.26 |
| FCF / Share | -0.47 | OCF / Share | -0.38 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 2.85% | FCF Conversion | 49.66% |
| SBC-Adj. FCF | -49.69 M | Growth Momentum | -60.09 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 134.48 M | 139.93 M | 89.08 M | 49.01 M | 22.59 M |
| Net Income | -38.94 M | -27.46 M | -48.61 M | -66.76 M | -48.69 M |
| EPS (Diluted) | -0.95 | -0.71 | -1.41 | -2.41 | -3.57 |
| Gross Profit | 103.01 M | 98.94 M | 53.77 M | 21.33 M | 4.52 M |
| Operating Income | -48.19 M | -36.86 M | -50.09 M | -63.32 M | -52.79 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 38.55 M | 34.37 M | 29.05 M | 25.98 M | 24.50 M |
| SG&A Expenses | 112.65 M | 101.43 M | 74.80 M | 58.67 M | 32.81 M |
| D&A | 3.27 M | 3.58 M | 4.08 M | 3.88 M | 3.98 M |
| Interest Expense | 19,000.0 | 21,000.0 | 3.31 M | 4.95 M | 3.68 M |
| Income Tax | 66,000.0 | 50,000.0 | 20,000.0 | 9,000.0 | 8,000.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 311.81 M | 318.56 M | 182.55 M | 150.16 M | 192.72 M |
| Total Liabilities | 36.13 M | 37.33 M | 22.19 M | 60.26 M | 54.48 M |
| Shareholders' Equity | 275.68 M | 281.24 M | 160.36 M | 89.90 M | 138.24 M |
| Total Debt | — | — | 0.0 | 40.17 M | 39.76 M |
| Cash & Equivalents | 19.95 M | 16.71 M | 9.69 M | 11.83 M | 24.36 M |
| Current Assets | 287.46 M | 293.82 M | 168.41 M | 134.56 M | 176.30 M |
| Current Liabilities | 26.25 M | 25.88 M | 20.90 M | 17.24 M | 11.08 M |
{"event":"ticker_viewed","properties":{"ticker":"RXST","listing_kind":"stock","pathname":"/stocks/rxst","exchange":"Nasdaq","country":"US"}}